Paul Breillat/LinkedIn
Jul 8, 2026, 19:25
Paul Breillat: Nature Reviews Rheumatology Highlights Our VEXAS Syndrome Research
Paul Breillat, Assistant Clinical Fellow in Internal Medicine and Clinical Immunology at Cochin Hospital, shared a post on LinkedIn about a recent article by Holly Webster, published in Nature Reviews Rheumatology, adding:
“Happy to see that our latest article on monocyte dysfunction and inflammatory cell death in VEXAS syndrome has been highlighted by Nature Reviews Rheumatology!
Many thanks to all the collaborators and co-authors who made this work possible.”
Title: Dysfunctional UBA1-mutated myeloid cells promote inflammation in VEXAS syndrome
Authors: Holly Webster
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 13, 2026, 14:42Bruno Pougault: The Global Momentum Behind Innovation in Thrombosis and Hemostasis
-
Jul 13, 2026, 14:34Julie Vassart: Optimizing DOAC Detection in an Evolving Anticoagulant Landscape at ISTH 2026
-
Jul 13, 2026, 13:57Heghine Khachatryan: The Diagnostic Dilemma of Non-Criteria Obstetric APS
-
Jul 13, 2026, 13:49Mitra Najafi: Translating Years of Innovation into Global Scientific Dialogue at ISTH 2026
-
Jul 13, 2026, 13:2810 Posts Not To Miss from ISTH 2026, Part 2
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026